| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |